# Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors

> **NCT01259479** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 9 (actual)

## Conditions studied

- Solid Tumors
- Brain Tumors
- Brain Metastases

## Interventions

- **DRUG:** Satraplatin

## Key facts

- **NCT ID:** NCT01259479
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12-03
- **Primary completion:** 2013-08-01
- **Final completion:** 2015-05-29
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01259479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01259479, "Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01259479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*